Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Aug 10, 2026
Multiple Myeloma Complicating Breast Cancer During Treatment: A Case Report.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Circ17399 RNA promotes melanoma progression through the miR-150-3p/ITM2C Axis and ALKBH5-mediated FOXM1 m6A modification.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Targeting Oncogenic KRAS Using Peptide Nucleic Acid Oligomers Attached to Cell-Penetrating Peptides.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Enzyme/Reactive Oxygen Species-Dually Activated Hyaluronic Acid Nanocarriers Enable Celastrol Delivery for Site-Specific Therapy of Inflammatory Bowel Diseases and Colorectal Cancer.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Impact of structured reporting on interpretability of PSMA PET/CT in prostate cancer staging-towards standardised clinical implementation.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Interstitial lung disease in metastatic breast cancer: a landscape review using SEER-Medicare.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Watch-and-wait after immunotherapy-containing neoadjuvant treatment in pMMR/MSS locally advanced rectal cancer: a multicenter real-world study.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Urinary protein semi-quantification in immunochemotherapy for bladder cancer: markers of clinical outcomes.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Deep Learning-Driven Anticancer Drug Discovery: Emodepside as a Potential Therapeutic Candidate for Triple-Negative Breast Cancer.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Association of tumor Schwann cells with epithelial-mesenchymal transition and immune-suppressive microenvironment in triple-negative breast cancer.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Real-world comparative evaluation of immune-related toxicities in non-small cell lung cancer patients treated with immune-checkpoint inhibitors in Greece and Sweden.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Patient-reported outcomes in clinical trials leading to breast cancer drug approvals: are we making them count?
Read at PubMed CentralPubMed Central · Aug 10, 2026
Biomarker-driven neoadjuvant immunotherapy in triple-negative breast cancer: emerging therapeutic targets FOXP3 and WT1.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Integrative multi-omics reveals the POSTN(+) CAF-APOE(+) macrophage axis drives immunosuppression and progression in prostate cancer.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Breast Cancer Knowledge, Awareness and Screening Practices Among Female Healthcare Workers in Al-Mukalla, Yemen.
Read at PubMed CentralPubMed Central · Aug 10, 2026
IL27 expression and IL27RA-dependent cellular responses are associated with biochemical recurrence and immune-regulatory features in prostate cancer.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Self-reported racial and ethnic discrimination in patient-provider interactions and the initiation of adjuvant therapies for breast cancer in the pathways study.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Randomized phase 2 trial of a PARP inhibitor TSL-1502 in germline BRCA-mutated, HER2-negative locally advanced/metastatic breast cancer.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Building a Natural Language Processing Augmented Information Support System to Enhance Supportive Care for Patients With Prostate Cancer and Families: User-Centered, Iterative Approach.
Read at PubMed CentralPubMed Central · Aug 10, 2026
Single-cell multiomics identifies an ALDH9A1-carnitine signaling axis driving resistance of NSCLC to immunotherapy.
Read at PubMed Central